[Form 4] AVANOS MEDICAL, INC. Insider Trading Activity

AVANOS MEDICAL, INC.

Rhea-AI Filing Summary

AVANOS MEDICAL, INC. SVP and Chief Financial Officer Scott Michael Galovan reported equity award activity in company stock. On March 6, 2026, he acquired 5,907 shares of common stock at $13.79 per share through the vesting of performance-based restricted share units.

On the same date, he disposed of multiple blocks of common stock at $13.79 per share to satisfy tax withholding obligations tied to the vesting of performance-based and time-based restricted share units, rather than through open-market sales. After these transactions, he directly owned 111,462 shares of Avanos common stock.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Galovan Scott Michael

Role SVP, Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Common Stock	5,907	$13.79	$81K
Exercise Price or Tax Liability	Common Stock	2,356	$13.79	$32K
Exercise Price or Tax Liability	Common Stock	1,057	$13.79	$15K
Exercise Price or Tax Liability	Common Stock	2,041	$13.79	$28K

Holdings After Transaction: Common Stock — 111,462 shares (Direct)

Footnotes (4)

1. F1. Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2026. Each PRSU is the economic eqiuvalent of one share of Common Stock.
2. F2. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 5,907 PRSUs which vested on March 6, 2026.
3. F3. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 2,649 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2026. Each TRSU is the economic equivalent of one share of Common Stock.
4. F4. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 5,172 TRSUs which: (i) were awarded to the Reporting Person on March 6, 2024 and (ii) vested on March 6, 2026. Each TRSU is the economic equivalent of one share of Common Stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did AVNS CFO Scott Galovan report on this Form 4?

Scott Michael Galovan reported the vesting of equity awards and related share movements. He acquired 5,907 shares of Avanos common stock from performance-based restricted share units, then surrendered several share blocks to cover tax withholding obligations tied to those and other restricted share units.

Did the AVNS CFO buy or sell shares on the open market in this filing?

The filing does not show open-market buying or selling. Reported dispositions use code F, indicating shares were surrendered back to Avanos to pay tax withholding on vested restricted share units, rather than sold through market transactions to third-party buyers.

How many Avanos (AVNS) shares did the CFO receive from award vesting?

He received 5,907 shares of Avanos common stock at $13.79 per share from vesting performance-based restricted share units awarded on March 6, 2023. Each unit is described as the economic equivalent of one share of common stock in the filing footnotes.

What was Scott Galovan’s Avanos share ownership after these Form 4 transactions?

After the reported transactions, Scott Michael Galovan directly owned 111,462 shares of Avanos common stock. This figure reflects the net result of the restricted share unit vesting and the shares surrendered to Avanos to cover associated tax withholding obligations on the vesting events.

Why were some AVNS shares classified as disposals in the Form 4?

Disposals are coded F, meaning shares were delivered to Avanos to satisfy tax liabilities. The filing states these disposals reflect shares surrendered upon vesting of performance-based and time-based restricted share units, rather than discretionary sales initiated to raise personal cash proceeds.

What types of equity awards vested for the AVNS CFO in this report?

The footnotes describe vesting of performance-based restricted share units (PRSUs) and time-based restricted share units (TRSUs). Each PRSU or TRSU is the economic equivalent of one Avanos common share, and vesting triggered both share delivery and related tax-withholding surrenders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 09:48 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Galovan Scott Michael

(Last) (First) (Middle)

5405 WINDWARD PARKWAY

SUITE 100

(Street)

ALPHARETTA GA 30004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVANOS MEDICAL, INC. [ AVNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		M		5,907(1)	A	$13.79	116,916	D
Common Stock	03/06/2026		F(2)		2,356	D	$13.79	114,560	D
Common Stock	03/06/2026		F(3)		1,057	D	$13.79	113,503	D
Common Stock	03/06/2026		F(4)		2,041	D	$13.79	111,462	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2026. Each PRSU is the economic eqiuvalent of one share of Common Stock.

2. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 5,907 PRSUs which vested on March 6, 2026.

3. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 2,649 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2026. Each TRSU is the economic equivalent of one share of Common Stock.

4. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 5,172 TRSUs which: (i) were awarded to the Reporting Person on March 6, 2024 and (ii) vested on March 6, 2026. Each TRSU is the economic equivalent of one share of Common Stock.

Remarks:

	/s/ John S. Fischer, as attorney-in-fact for Scott M. Galovan	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.